Get the Stockscreener App
0.0491
5.59%
0.0026
Inhibitor Therapeutics Inc Stock (INTI) Forecast
The Inhibitor Therapeutics Inc (INTI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.075, representing a +52.68% increase from the current price of $0.0491. The highest analyst price target is $0.0787, and the lowest is $0.0712.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INTI Price Target
Average 0.0849
(+72.85% Upside)
Long-term INTI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Inhibitor Therapeutics Inc financial reports and earnings history, Inhibitor Therapeutics Inc (INTI) stock could reach $0.2873 by 2030, $0.7883 by 2040 and $1.318 by 2050. See the projected annual prices until 2050 of the Inhibitor Therapeutics Inc stock below:
- Inhibitor Therapeutics Inc (INTI) is expected to reach an average price of $0.5599 in 2035, with a high prediction of $0.5704 and a low estimate of $0.4403. This indicates an $1,040% rise from the last recorded price of $0.0491.
- Inhibitor Therapeutics Inc (INTI) stock is projected to chart a bullish course in 2040, with an average price target of $0.7511, representing an $1,430% surge from its current level. The forecast ranges from a conservative $0.7511 to a sky-high $0.7883.
- Our analysts predict Inhibitor Therapeutics Inc (INTI) to jump 1,656% by 2045, soaring from $0.8621 to an average price of $0.8621, potentially reaching $0.9103. While $0.8621 is the low estimate, the potential upside is significant.
- Inhibitor Therapeutics Inc (INTI) stock is expected to climb by 2050, reaching an average of $1.2764, a $2,500% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.318 and $1.2788, respectively, highlighting the market's uncertainty.
Inhibitor Therapeutics Inc Stock (INTI) Year by Year Forecast
Inhibitor Therapeutics Inc Stock (INTI) Price Forecast for 2025
Inhibitor Therapeutics Inc Stock (INTI) is expected to reach an average price of $0.0718 in 2025, with a high prediction of $0.1065 and a low estimate of $0.0372. This indicates an +46.31% rise from the last recorded price of $0.0491.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.0753 | $0.0712 | $0.0787 | +53.38% |
| June, 2025 | $0.0513 | $0.06 | $0.0685 | +4.47% |
| July, 2025 | $0.0788 | $0.0493 | $0.082 | +60.46% |
| August, 2025 | $0.0849 | $0.0849 | $0.0926 | +72.99% |
| September, 2025 | $0.0851 | $0.0851 | $0.0886 | +73.29% |
| October, 2025 | $0.0642 | $0.0614 | $0.067 | +30.78% |
| November, 2025 | $0.0667 | $0.0934 | $0.0968 | +35.84% |
| December, 2025 | $0.1018 | $0.0986 | $0.1065 | +107.36% |
Inhibitor Therapeutics Inc Stock (INTI) Price Forecast for 2026
The predicted value for Inhibitor Therapeutics Inc (INTI) in 2026 is set at an average of $0.1148. Estimates vary from a peak of $0.156 to a trough of $0.0736, indicating an +133.80% surge from the present price of $0.0491.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0666 | $0.0736 | $0.0945 | +35.68% |
| February, 2026 | $0.1079 | $0.0752 | $0.1116 | +119.85% |
| March, 2026 | $0.1123 | $0.1123 | $0.1204 | +128.77% |
| April, 2026 | $0.0921 | $0.10 | $0.1151 | +87.68% |
| May, 2026 | $0.0875 | $0.0857 | $0.0892 | +78.18% |
| June, 2026 | $0.095 | $0.1225 | $0.1264 | +93.42% |
| July, 2026 | $0.1206 | $0.126 | $0.1343 | +145.60% |
| August, 2026 | $0.0909 | $0.0979 | $0.1135 | +85.15% |
| September, 2026 | $0.1371 | $0.099 | $0.1412 | +179.23% |
| October, 2026 | $0.1371 | $0.1397 | $0.1483 | +179.26% |
| November, 2026 | $0.1173 | $0.1252 | $0.1416 | +138.95% |
| December, 2026 | $0.156 | $0.11 | $0.156 | +217.72% |
Inhibitor Therapeutics Inc Stock (INTI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Inhibitor Therapeutics Inc (INTI) is $0.163, with a high forecast of $0.2039 and a low forecast of $0.1222. This indicates an +232.07% increase from the last price of $0.0491.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1632 | $0.1517 | $0.1622 | +232.44% |
| February, 2027 | $0.1466 | $0.1534 | $0.1548 | +198.68% |
| March, 2027 | $0.1152 | $0.1222 | $0.1391 | +134.62% |
| April, 2027 | $0.1402 | $0.1229 | $0.1708 | +185.58% |
| May, 2027 | $0.1641 | $0.1671 | $0.1761 | +234.13% |
| June, 2027 | $0.1425 | $0.1504 | $0.1681 | +190.22% |
| July, 2027 | $0.1856 | $0.1343 | $0.1856 | +278.00% |
| August, 2027 | $0.1911 | $0.1808 | $0.19 | +289.12% |
| September, 2027 | $0.1747 | $0.1747 | $0.1813 | +255.90% |
| October, 2027 | $0.1467 | $0.1465 | $0.1551 | +198.78% |
| November, 2027 | $0.1689 | $0.1477 | $0.2004 | +244.06% |
| December, 2027 | $0.1946 | $0.1945 | $0.2039 | +296.28% |
Inhibitor Therapeutics Inc Stock (INTI) Price Forecast for 2028
In 2028, Inhibitor Therapeutics Inc (INTI) is projected to reach an average price of $0.2021, with a high projection of $0.2457 and a low estimate of $0.1586. This indicates an +311.68% rise from the last price of $0.0491.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1626 | $0.1713 | $0.1857 | +231.14% |
| February, 2028 | $0.2152 | $0.1586 | $0.2152 | +338.29% |
| March, 2028 | $0.2082 | $0.2082 | $0.2178 | +323.99% |
| April, 2028 | $0.2004 | $0.2004 | $0.2078 | +308.08% |
| May, 2028 | $0.1706 | $0.1706 | $0.1803 | +247.35% |
| June, 2028 | $0.1939 | $0.1711 | $0.23 | +294.96% |
| July, 2028 | $0.2211 | $0.2211 | $0.2317 | +350.25% |
| August, 2028 | $0.1759 | $0.1829 | $0.2118 | +258.30% |
| September, 2028 | $0.2392 | $0.1825 | $0.2448 | +387.07% |
| October, 2028 | $0.2356 | $0.2356 | $0.2457 | +379.77% |
| November, 2028 | $0.2054 | $0.2133 | $0.2343 | +318.41% |
| December, 2028 | $0.197 | $0.1944 | $0.1997 | +301.31% |
Inhibitor Therapeutics Inc Stock (INTI) Price Forecast for 2029
The 2029 price forecast for Inhibitor Therapeutics Inc Stock (INTI) is $0.2551 on average, with a high prediction of $0.304 and a low estimate of $0.2063. This represents an +419.61% increase from the previous price of $0.0491.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2222 | $0.2537 | $0.2596 | +352.54% |
| February, 2029 | $0.2476 | $0.2476 | $0.2596 | +404.23% |
| March, 2029 | $0.2002 | $0.2072 | $0.2379 | +307.77% |
| April, 2029 | $0.2683 | $0.2063 | $0.2744 | +446.46% |
| May, 2029 | $0.2584 | $0.263 | $0.2735 | +426.21% |
| June, 2029 | $0.2306 | $0.2385 | $0.2608 | +369.68% |
| July, 2029 | $0.2212 | $0.218 | $0.2244 | +350.49% |
| August, 2029 | $0.2885 | $0.2829 | $0.2892 | +487.50% |
| September, 2029 | $0.2639 | $0.2741 | $0.2741 | +437.51% |
| October, 2029 | $0.2245 | $0.2315 | $0.2544 | +357.24% |
| November, 2029 | $0.2694 | $0.2297 | $0.304 | +448.75% |
| December, 2029 | $0.2853 | $0.2903 | $0.3013 | +481.08% |
Inhibitor Therapeutics Inc Stock (INTI) Price Forecast for 2030
Inhibitor Therapeutics Inc Stock (INTI) is expected to reach an average price of $0.2949 in 2030, with a high forecast of $0.3484 and a low forecast of $0.2414. This signifies an +500.57% surge from the last price of $0.0491.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.2492 | $0.2578 | $0.2873 | +407.45% |
| February, 2030 | $0.3188 | $0.2414 | $0.3188 | +549.29% |
| March, 2030 | $0.3163 | $0.312 | $0.3152 | +544.18% |
| April, 2030 | $0.29 | $0.3006 | $0.3006 | +490.59% |
| May, 2030 | $0.254 | $0.254 | $0.28 | +417.35% |
| June, 2030 | $0.2982 | $0.2531 | $0.3336 | +507.23% |
| July, 2030 | $0.3123 | $0.3177 | $0.3292 | +535.96% |
| August, 2030 | $0.2739 | $0.2826 | $0.3138 | +457.82% |
| September, 2030 | $0.3484 | $0.2648 | $0.3484 | +609.57% |
| October, 2030 | $0.3314 | $0.3314 | $0.3431 | +575.00% |
| November, 2030 | $0.3156 | $0.3156 | $0.3271 | +542.86% |
| December, 2030 | $0.2779 | $0.2779 | $0.2935 | +465.91% |
0.08%
0.00%
Cap:
|
Volume (24h):